Related Articles
Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma
Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies
Serum anti-p53 antibodies in patients with lung cancer.
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A
Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma